Polymorphism Genotype Frequency N Warfarin weekly dose P valuea
    (%)   Median 25th-75th  
MMP9 rs17576 (Gln279Arg, A>G) AAb 41.9 95 25.00 16.25-33.75 0.01
AG 48.0 109 26.25 17.50-35.00
GG 10.1 23 16.25 8.75-26.25
G allele 34.2        
TNFSF14rs2291668 (c.147C>T) CCb 71.4 162 23.75 17.50-35.00 0.98
CT 25.5 58 26.25 13.75-34.06
TT 3.1 07 23.75 26.25-35.00
T allele 15.9        
TNFSF14 rs344560 (Lys214Glu, G>A) GGb 86.4 196 24.38 17.50-35.00 0.75
GA 12.7 29 25.00 15.00-30.63
AA 0.9 02 29.38 Ø
A allele 7.3        
LTA rs1041981 (Thr60Asn, C>A) CCb 40.8 92 25.00 15.00-34.69 0.22
CA 48.2 110 23.75 16.25-32.81
AA 11.0 25 28.75 20.00-36.88
A allele 35.2 160      
LTA rs909253 (c.252T>C) TTb 40.8 93 25.00 15.00-34.38 0.19
CT 48.7 110 23.75 26.25-32.81
CC 10.5 24 28.75 20.00-37.81
C allele 34.8        
aKruskall-Wallis test and Bonferroni correction for multiple comparison test (GG was different from AA+AG genotypes (p<0.05). bAncestral allele (www.ncbi.nlm.nih.gov).
Table 2: MMP9, LTA and TNFSF14 polymorphisms frequencies and warfarin weekly dose